
India-origin pharma patents jump four-fold, innovation pipeline tops 1,095 Report
It highlighted four key drivers behind the momentum like nearly $5 billion in government funding for early-stage and translational research, stronger academia-industry collaboration, regulatory reforms that have reduced drug development timelines from 180-270 days to 60-120 days and shared research and manufacturing infrastructure such as Genome Valley and C-CAMP.
15/7/2026



